Pages
-
-
Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia
-
-
Prediction of spatial-temporal brain drug distribution with a novel mathematical model
-
-
Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft
-
-
Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration
-
-
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
-
-
Pregnancy affects the pharmacokinetics of sildenafil and its metabolite in the rabbit
-
-
Impact of post-hatching maturation on the pharmacokinetics of paracetamol in zebrafish larvae
-
-
How to scale clearance from adults to children for drugs undergoing hepatic metabolism? Insights from advanced PBPK modelling and simulation
-
-
First-pass and systemic metabolism of cytochrome P450 3A substrates in neonates, infants, and children
-
-
Novel treatments for advanced thyroid cancer and elucidation of biomarkers
-
-
Pharmacological properties of betrixaban
-
-
Sticky & Dirty Proteins – or on the poorly characterised, peculiar, pharmacokinetic and immunostimulatory aspects of biopharmaceuticals
-
-
Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease
-
-
Drug Dosing in Obese Children Challenges and Evidence-Based Strategies
-
-
Revisiting atenolol as a low passive permeability marker
-
-
Pharmacogenetics of sunitinib in metastatic renal cell carcinoma
-
-
Pharmacokinetic and pharmacodynamic analysis in anesthesia : a modeling odyssey
-
-
Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy
-
-
Mind the time : 24-hour rhythms in drug exposure and effect
-
-
Statin use decreases coagulation in users of vitamin K antagonists
-
-
The impact of obesity on the pharmacokinetics of drugs in adolescents and adults
-
-
Dose optimization of oral targeted therapies in oncology
-
-
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients
-
-
Non-invasive monitoring of pharmacokinetics and pharmacodynamics for pharmacological drug profiling in children and adolescents
Pages
